Applied Biosystems - Products, news, whitepaper, companies, specialist information

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture p more
QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

Corbett, QIAGEN, ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene_TM Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument patents. more
Invitrogen and Applied Biosystems Complete Merger

Invitrogen Corporation and Applied Biosystems Inc. announced the successful completion of their merger transaction. The new company will be named Life Technologies Corporation and is traded on the NASDAQ Global Select Market under the ticker symbol "LIFE" beginning November 24, 2008. “This is an e more

White papers Applied Biosystems

siRNA Silencing of Lamin A and Quantification of the Knockdown Effect via qPCR

Lamins are structural proteins which form a thin fibrous layer called the nuclear lamina. Currently, three types of lamins are known in mammalian cells: lamin A, B, and C. Lamins may be involved in DNA replication, chromatin organization, differentiation, nuclear structural support, nuclear envelope reassembly, and several other processes. Mutations of lamin A can cause muscular dystrophy, dilated cardiomyopathy, familiar partial lipodystrophy [3], and other disorders. For the detailed analysis of the different functions of this more than 70 kDa large protein, the expression should be blocked. more